Related Experiment Video

Updated: Jun 6, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Knockdown of TSP50 inhibits cell proliferation and induces apoptosis in P19 cells

Liang Zhou1, Yong-Li Bao, Yu Zhang

  • 1National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China.

IUBMB Life
|November 19, 2010
PubMed

Insights

Testes-specific protease 50 (TSP50) plays a key role in cancer cell behavior. Downregulating TSP50 in stem cells reduced proliferation and migration while increasing apoptosis, suggesting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Testes-specific protease 50 (TSP50) is a threonine protease reactivated in breast cancer.
  • TSP50 is negatively regulated by the p53 gene.
  • The precise biological function of TSP50 remains largely uncharacterized.

Purpose of the Study:

  • To investigate the biological function of TSP50.
  • To determine the effect of TSP50 gene knockdown on P19 murine embryonal carcinoma stem cell phenotype.

Main Methods:

  • RNA interference (RNAi) was used to knockdown TSP50 gene expression.
  • P19 murine embryonal carcinoma stem cells were utilized.
  • Cell proliferation, colony formation, migration, and apoptosis assays were performed.
  • Sensitivity to doxorubicin-induced apoptosis and caspase-3 activation were analyzed.

Main Results:

  • TSP50 knockdown significantly reduced cell proliferation, colony formation, and migration.
  • Downregulation of TSP50 induced apoptosis in P19 cells.
  • TSP50 knockdown enhanced sensitivity to doxorubicin-induced apoptosis.
  • Caspase-3 activation was implicated in the observed apoptosis.

Conclusions:

  • TSP50 plays a crucial role in regulating the proliferation, migration, and survival of P19 stem cells.
  • Targeting TSP50 may represent a novel therapeutic strategy for enhancing chemotherapy efficacy, particularly in conjunction with agents like doxorubicin.
  • Further research into TSP50's role in cancer is warranted.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...